Cited by 131Alzheimer's disease research and treatmentsSignaling Pathways in DiseaseDementia and Cognitive Impairment Research

Cancer and Alzheimer’s disease inverse relationship: an age-associated diverging derailment of shared pathways

Lanni, Cristina, Masi, Mirco, Racchi, Marco, Govoni, Stefano·2021·Molecular Psychiatry

Abstract

Several epidemiological studies show an inverse association between cancer and Alzheimer's disease (AD). It is debated whether this association is the consequence of biological mechanisms shared by both these conditions or may be related to the pharmacological treatments carried out on the patients. The latter hypothesis, however, is not sustained by the available evidence. Hence, the focus of this review is to analyze common biological mechanisms for both cancer and AD and to build up a biological theory useful to explain the inverse correlation between AD and cancer. The review proposes a hypothesis, according to which several molecular players, prominently PIN1 and p53, have been investigated and considered involved in complex molecular interactions putatively associated with the inverse correlation. On the other hand, p53 involvement in both diseases seems to be a consequence of the aberrant activation of other proteins. Instead, PIN1 may be identified as a novel key regulator at the crossroad between cancer and AD. PIN1 is a peptidyl-prolyl cis-trans isomerase that catalyzes the cis-trans isomerization, thus regulating the conformation of different protein substrates after phosphorylation and modulating protein function. In particular, trans-conformations of Amyloid Precursor Protein (APP) and tau are functional and "healthy", while cis-conformations, triggered after phosphorylation, are pathogenic. As an example, PIN1 accelerates APP cis-to-trans isomerization thus favo…

Integrity signals

Registry

Crossref · 10.1038/s41380-020-0760-2

Cites

209 of 209 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

2 retracted

Flagged first, then by citations

3 of the 212 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Lanni, C., Masi, M., Racchi, M., & Govoni, S.
Affiliations
University of Pavia (IT)
Corresponding author
Govoni, Stefano
Venue
Molecular Psychiatry
Published
2020-05-07
Volume
26
Issue
1
Pages
280-295
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W3022858905
Cited by
130
References
212
Citations by year
2026: 20 · 2025: 19 · 2024: 26 · 2023: 17 · 2022: 27 · 2021: 15 · 2020: 5
FWCI
2.04
Type
journal article
Language
en
Open access
closed
Locations
  • Molecular Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Alzheimer's disease, cancer, inverse association, Pin1, peptidyl-prolyl isomerase, p53, amyloid precursor protein, tau hyperphosphorylation, non-amyloidogenic pathway, amyloidogenic pathway, mild cognitive impairment, age of onset, cancer risk, neurodegenerative dementia
MeSH terms
NIMA-Interacting Peptidylprolyl Isomerase, Aging, Alzheimer Disease, Humans, Neoplasms, Phosphorylation, Tumor Suppressor Protein p53, Amyloid beta-Protein Precursor, Peptidylprolyl Isomerase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review